| CAS ID: | 5119-48-2 |
| Molecular Formula: | C28H38O6 |
| Molecular Weight: | 470.6 g/mol |
| Monoisotopic Mass: | 470.2668 g/mol |
| Class: | Small Molecule |
| Natural Product: | Yes |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C28H38O6/c1-14-11-21(33-25(32)17(14)13-29)15(2)18-5-6-19-16-12-24-28(34-24)23(31)8-7-22(30)27(28,4)20(16)9-10-26(18,19)3/h7-8,15-16,18-21,23-24,29,31H,5-6,9-13H2,1-4H3/t15-,16-,18+,19-,20-,21+,23-,24+,26+,27-,28+/m0/s1 | See All |
| InChI Key: | DBRXOUCRJQVYJQ-CKNDUULBSA-N | |
| Smiles: | C[C@H]([C@H]1CC(=C(CO)C(=O)O1)C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C | See All |
| Molfile: | Download |
Reference Record 1
| PubMed ID | 22900077 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | cells apoptosis | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 2
| PubMed ID | 22900077 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation | ||
| Process III | |||
| Mechanism | |||
Reference Record 3
| PubMed ID | 19439083 | Target ID | |
| Uniprot ID | Name | ||
| Model | Fibrosis Disease | Cystic fibrosis | |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | |||
| Mechanism | |||
| PubChem: | 265237 |
| ChEMBL: | CHEMBL517080 |